Definitive Healthcare Corp. DH
0.95
(0.06)
(5.94%)
as of 25 Sep
- Market cap
- $146.3M
- P/E
- 0.0×
Follow DH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.38 | 0.54 | 1.27 | 1.74 | |
P/FCF ratio |
3.07 | 4.76 | 8.26 | 11.70 | |
P/Operating CF |
7.67 | 11.13 | 112.53 | 26.86 | |
P/B ratio |
0.47 | 0.68 | 0.81 | 1.08 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.28 | 0.48 | 1.20 | 1.66 | |
EV/EBITDA |
1.46 | 2.38 | 6.55 | 8.35 | |
EV/Operating CF |
1.57 | 2.89 | 5.39 | 6.80 | |
EV/FCF |
2.27 | 4.19 | 7.83 | 11.17 | |
Quick Ratio |
1.66 | 1.55 | 1.49 | 1.43 | |
Current Ratio |
1.86 | 1.75 | 1.64 | 1.60 | |
Net Debt/EBITDA |
(2.10) | (1.17) | (1.48) | (2.00) | |
Debt/Assets |
32.33% | 31.62% | 22.41% | 22.10% | |
Debt/Equity |
0.86 | 0.85 | 0.43 | 0.43 | |
Asset Turnover |
0.37 | 0.36 | 0.26 | 0.25 | |
Operating CF/Net income |
(2.11) | (0.08) | (0.29) | (1.06) | |
Capex/Depreciation |
(0.17) | (0.01) | (0.12) | (0.13) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
12.24% | 11.62% | 16.18% | 12.58% | |
Selling, General and Administrative Expense of Revenue |
54.29% | 56.61% | 56.00% | 54.53% | |
Intangible Assets out of Total Assets |
0.45 | 0.46 | 0.60 | 0.63 | |
Share Based Compensation of Revenue |
9.52% | 9.33% | 13.26% | 11.13% | |
Graham Net Nets |
(0.78) | (0.61) | (0.32) | (0.28) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(192.77%) | (131.71%) | (43.55%) | (41.13%) | |
Free Cash Flow Yield |
32.52% | 21.02% | 12.11% | 8.55% | |
Revenue per Share |
0.52 | 0.53 | 0.58 | 0.58 | |
Operating CF per Share |
0.11 | 0.11 | 0.03 | 0.15 | |
Capex per Share |
(0.03) | (0.03) | (0.04) | (0.02) | |
Free Cash Flow per Share |
0.08 | 0.08 | (0.02) | 0.13 | |
Cash per Share |
1.74 | 1.70 | 1.70 | 1.79 | |
Shareholders Equity per Share |
1.78 | 1.82 | 3.55 | 3.75 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.78 | 1.82 | 3.55 | 3.75 | |
Free Cash Flow |
8.51 | 8.36 | (1.72) | 13.41 | |
Working Capital |
111.03 | 105.35 | 100.82 | 92.44 | |
Capital Expenditures |
(2.94) | (3.20) | (4.44) | (2.28) | |
Net Current Asset Value |
(68.87) | (78.28) | (98.89) | (119.54) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.06 | 0.07 | 0.04 | |
Net Profit Margin |
(9.82%) | (247.85%) | (15.14%) | (24.71%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
34.24 | 40.93 | 52.61 | 35.06 | |
Average Payables |
6.21 | 7.12 | 7.18 | 9.27 | |
Average Assets |
633.49 | 661.70 | 912.44 | 968.59 | |
Average Common Equity |
299.55 | 313.30 | 493.09 | 542.62 |
Columns are period end dates